OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular landscape of recurrent cervical cancer
Divya Adiga, Sangavi Eswaran, Deeksha Pandey, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103178-103178
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
Rahul Bhattacharjee, Sabya Sachi Das, Smruti Sudha Biswal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 174, pp. 103675-103675
Open Access | Times Cited: 117

Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer
Marzieh Ramezani Farani, Maryam Azarian, Hamid Heydari Sheikh Hossein, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 1305-1318
Open Access | Times Cited: 89

A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127375-127375
Closed Access | Times Cited: 87

Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5167-5167
Open Access | Times Cited: 44

Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature
Ottavia D’Oria, Giorgio Bogani, Ilaria Cuccu, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 25, Iss. 1, pp. 55-65
Closed Access | Times Cited: 29

Chemoradiotherapy-induced ACKR2+ tumor cells drive CD8+ T cell senescence and cervical cancer recurrence
Dongfang Dai, Yifei Pei, Biqing Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101550-101550
Open Access | Times Cited: 13

Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis
Jiawen Kang, Jingwen Jiang, Xiaoqing Xiang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7

The research progress on radiation resistance of cervical cancer
Мейли Лианг, Liying Sheng, Yumin Ke, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6

Biological functions of extracellular vesicle double C2-like domain beta in cervical cancer
Sangavi Eswaran, Samatha Bhat, Dinesh Upadhya, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Identification of differentially expressed MiRNA clusters in cervical cancer
S. Sriharikrishnaa, Padacherri Vethil Jishnu, Vinay Koshy Varghese, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Validation of cervical cancer genetic signature in minimally invasive samples
RAFAELA L.F. DE ANDRADE, A Ramos, Fábio Ribeiro Queiroz, et al.
Anais da Academia Brasileira de Ciências (2025) Vol. 97, Iss. 1
Open Access

miR-627-5p inhibits malignant progression of cervical cancer by targeting ANGPTL4
Xinghua Wu, Kai Lin, Chen Gao, et al.
European Journal of Histochemistry (2025) Vol. 69, Iss. 2
Open Access

Endothelial cell-specific molecule 1 drives cervical cancer progression
Jingjing Lu, Qin Liu, Lixia Zhu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 17

DOC2B is a negative regulator of Wnt/β-catenin signaling pathway in cervical cancer
Divya Adiga, Samatha Bhat, Sanjiban Chakrabarty, et al.
Pharmacological Research (2022) Vol. 180, pp. 106239-106239
Closed Access | Times Cited: 16

HPV16 E6 promoting cervical cancer progression through down‐regulation of miR‐320a to increase TOP2A expression
Jianing Zhang, Xiaohui Yu, Yi Guo, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 3

Fabrication and application of cisplatin-loaded mesoporous magnetic nanobiocomposite: a novel approach to smart cervical cancer chemotherapy
Mahdieh Darroudi, Seyedeh Elnaz Nazari, Fereshteh Asgharzadeh, et al.
Cancer Nanotechnology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14

Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence
Samatha Bhat, Divya Adiga, Vaibhav Shukla, et al.
Cell Biology and Toxicology (2021) Vol. 38, Iss. 2, pp. 237-258
Open Access | Times Cited: 20

In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review
Yenddy Carrero, Diana E. Callejas, Jesús Mosquera
Translational Oncology (2021) Vol. 14, Iss. 5, pp. 101058-101058
Open Access | Times Cited: 19

Signaling Pathways in HPV-Induced Cervical Cancer: Exploring the Therapeutic Promise of RNA Modulation
Ali Hazazi, Farhan R. Khan, Fawaz Albloui, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155612-155612
Closed Access | Times Cited: 2

Risks of Cervical Cancer Recurrence After Fertility-Sparing Surgery and the Role of Human Papillomavirus Infection Types
Gulzhanat Aimagambetova, Gauri Bapayeva, Talshyn Ukybassova, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6318-6318
Open Access | Times Cited: 2

miR‐200a/b/‐429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
Anja Nilsen, Tiril Hillestad, Vilde E. Skingen, et al.
Molecular Oncology (2022) Vol. 16, Iss. 6, pp. 1402-1419
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top